期刊文献+

咪喹莫特对人皮肤鳞状细胞癌SCL-1细胞增殖和端粒酶活性的影响 被引量:2

Effect of imiquimod on proliferation and telomerase activity of human skin squamous cell carcinoma eell line SCL-1
原文传递
导出
摘要 目的 探讨咪喹莫特对人皮肤鳞状细胞癌SCL—1细胞增殖及端粒酶活性的影响。方法使用噻唑蓝(MTT)法检测药物处理后细胞生长抑制情况,细胞克隆形成试验检测药物处理后细胞增殖能力变化,倒置显微镜观察药物作用前后细胞形态改变;端粒酶重复序列扩增-酶联免疫吸附法(TRAP—ELISA)检测细胞端粒酶活性变化;细胞免疫组化和实时定量RT—PCR技术检测端粒酶活性相关c—Mvc基因表达情况。结果咪喹莫特能明显抑制SCL—1细胞增殖,并存在浓度依赖性。培养48h时,0,0.05,0.10,0.15和0.20g/L咪喹莫特组细胞增殖抑制率分别为0,31.3%±3.19%,44.7%±4.21%,49.2%±3.71%和71.6%±3.24%。咪喹莫特作用SCL—1细胞48h,端粒酶活性随药物浓度增高呈显著的递减关系。48h时,0.05和0.15g/L咪喹莫特组c—Myc mRNA和蛋白表达均低于空白对照组(P〈0.05)。结论 咪喹莫特可明显抑制SCL—1细胞的增殖,降低c—Myc基因表达,下调SCL—1肿瘤细胞端粒酶活性,可能是其抗癌作用的机制之一。 Objective To investigate the effect of imiquimod on the proliferation and telomerase activity of human skin squamous cell carcinoma cell line SCL-1. Methods Various concentrations of imiquimod was used to treat cultured SCL-1 cells in log phase. After 48 hours of culture, MTT assay and clonogenic assay were used to assess the proliferation of cells, the morphological alterations were observed by transmission electron microscopy, and telomerase activity was detected with telomeric repeat amplification protocol enzyme-linked immunoadsorbent assay (TRAP-ELISA). The protein and mRNA expressions of c-Myc were analyzed by immunohistochemistry and real time quantitative RT-PCR, respectively. Results The 48-hour treatment with imiquimod at the concentrations of 0.05, 0.10, 0.15 and 0.20 g/L down-regulated the proliferation of SCL-1 cells by 31.3% ± 3.19%, 44.7% ± 4.21%, 49.2%±3.71% and 71.6% ± 3.24%, respectively, and telomerase activity of SCL-1 cells was also inhibited by imiquimod; both effects were concentration-dependant. A reduction in mRNA and protein expressions of c-Myc was observed in SCL-1 cells after the treatment with imiquimod at 0.05 and 0.15 g/L, respectively (both P 〈 0.05). Conclusion Imiquimod can effectively inhibit the proliferation and telomerase activity of SCL-1 cells, decrease the expression of c-Myc gene, which may be associated with the mechanism of antitumor effect of imiquimod.
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2008年第3期176-179,共4页 Chinese Journal of Dermatology
基金 国家自然科学基金(30271198),教育部留学回国人员科研启动基金[2002]247号:
关键词 鳞状细胞 肿瘤细胞 培养的 细胞增殖 端粒 末端转移酶 咪喹莫特 Carcinoma, squamous cell Tumor cells, cultured Cell proliferation Telomerase Imiquimod
  • 相关文献

参考文献12

  • 1Wu A, Ichihashi M, Ueda M. Correlation of the expression of human telomerase subunits with telomerase activity in normal skin and skin tumors. Cancer, 1999, 86( 10): 2038-2044. 被引量:1
  • 2Schon M, Bung AB, Drewniok C, et al. Tumor-selective induction of apoptosis and the small-molecule immune response modifier imiquimod. J Natl Cancer Inst, 2003, 95 ( 15 ): 1138-1149. 被引量:1
  • 3Zhang DY, Wu J, Ye F, et al. Inhibition of cancer cell proliferation and prostaglandin E2 synthesis by Scutellaria baicalensis. Cancer Res, 2003, 63( 14):4037-4043. 被引量:1
  • 4Nakayama H, Yasui W, Yokozaki H, et al. Reduced expression of nm23 is associated with metastasis of human gastric carcinomas. Jpn J Cancer Res, 1993, 84(2): 184-190. 被引量:1
  • 5Terashima M, Takiyama I, Uesugi N, et al. Telomerase assay as a possible predictor of the response to anticancer chemotherapy. Anticancer Res, 2000, 20(1A): 293-297. 被引量:1
  • 6Klein D. Quantification using real-time PCR technology: applications and limitations. Trends Mol Med, 2002, 8(6): 257-260. 被引量:1
  • 7Stanley MA. Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential. Clin Exp Dermatol, 2002, 27 (7):571-577. 被引量:1
  • 8Aragona M, Maisano R, Panetta S, et al. Telomere length maintenance in aging and carcinogenesis. Int J Oncol, 2000, 17(5): 981 -992. 被引量:1
  • 9Pendino F, Tarkanyi I, Dudognon C, et al. Telomeres and telomerase: Pharmacological targets for new anticancer strategies? Curr Cancer Drug Targets, 2006, 6 (2): 147-180. 被引量:1
  • 10Carpenter EL, Vonderheide RH. Telomerase-based immunotherapy of cancer. Expert Opin Biol Ther, 2006, 6( 10): 1031-1039. 被引量:1

同被引文献47

  • 1张蕻,田峰,任连生,闻建华,白喜花.苏木精对移植性小鼠肝癌H_(22)的抑制作用[J].中国药物与临床,2006,6(4):294-295. 被引量:9
  • 2陈江,何春涤,王雅坤,王珍,金鑫,肖汀,姜奕,陈洪铎.咪喹莫特对皮肤鳞状细胞癌SCL-1细胞株增生及凋亡的影响[J].中华皮肤科杂志,2007,40(9):564-567. 被引量:2
  • 3Schon MP, Schon M. TLR7 and TLR8 as targets in cancer therapy.Oncogene, 2008, 27(2): 190-199. 被引量:1
  • 4Yokogawa M, Takaishi M, Nakajima K, et al. Imiquimod attenu-ates the growth of UVB-induced SCC in mice through Thl/Tkl7cells. Mol Carcinog, 2012 Mar 16. doi: 10.1002/mc.21901. 被引量:1
  • 5Drobits B, Holcmann M, Amberg N, et al. Imiquimod clears tumorsin mice independent of adaptive immunity by converting pDCsinto tumor-killing effector cells. J Clin Invest, 2012, 122(2):575-585. 被引量:1
  • 6Kalb ML, Glaser A, Stary G, et al. TRAIL* human plasmacytoiddendritic cells kill tumor cells in vitro: mechanisms of imiquimod-and IFN-a-mediated antitumor reactivity. J Immunol, 2012, 188(4): 1583-1591. 被引量:1
  • 7Huang SW, Chang CC, Lin CC, et al. Mcl-1 determines theimiquimod - induced apoptosis but not imiquimod - inducedautophagy in skin cancer cells. J Dermatol Sci, 2012, 65(3):170-178. 被引量:1
  • 8Li VW, Li WW. Antiangiogenesis in the treatment of skin cancer.J Drugs Dermatol, 2008, 7(1 Suppl 1): s17-s24. 被引量:1
  • 9Majewski S, Marczak M, Mlynarczyk B, et aJ. Imiquimod is astrong inhibitor of tumor cell-induced angiogenesis. Int J Dermatol,2005, 44(1): 14-19. 被引量:1
  • 10Jacob SE, Berman B, Nassiri M, et al. Topical application ofimiquimod 5% cream to keloids alters expression genes associ-ated with apoptosis. Br J Dermatol, 2003, 149 (Suppl 66): 62-65. 被引量:1

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部